Here is the synopsis of our sample research paper on Pharmaceutical Intervention in Type 2 Diabetes. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
This 7 page paper investigates the clinical research on Sitagliptin, a Class DPP-4 drug for treating this type of diabetes. Bibliography lists 6 sources.
Page Count:
7 pages (~225 words per page)
File: AM2_PP688051.doc
Buy This Term Paper »
Unformatted sample text from the term paper:
listed below. Citation styles constantly change, and these examples may not contain the most recent updates. Sitagliptin and Type 2 Diabetes Research
Compiled by 4/2011 Please
Millions of Americans and people the world over suffer from diabetes. Fortunately, there has been considerable research invested into treating diabetes.
While there is no cure, lifestyle changes coupled with various pharmaceutical products can in many cases keep this condition under control. Not surprisingly, some approaches are more effective than
are others. This is true even in regard to the various drugs used to control diabetes. The intent of this paper is to review the effectiveness of Sitagliptin,
a drug that is relatively new on the marketplace and one that only received approval from the Food and Drug Administration in October 2006.
Some twenty million Americans suffered from diabetes in 2005 (Deshpande, Harris-Hayes, and Schootman, 2005). Diabetes is ranked as the fourth leading cause of deaths relating to disease in
the world (International Diabetes Federation, 2007). While no one is immune to the impacts of diabetes, some cultures are more likely than others to succumb to the disease.
African Americans, for example, appear to be at greater risk for diabetes than other Americans (Skelly, Leeman, Carlson, et. Al., 2008). Some 11.4% of the African American
population aged twenty or more have diabetes (Skelly, Leeman, Carlson, et. Al., 2008). This translates into 2.7 million cases of diabetes within this population and an estimated 1.8 times
...